<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="5" ids="50113">Androgens</z:chebi> have been used in the treatment of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndromes without a clear understanding of their mechanism of action </plain></SENT>
<SENT sid="1" pm="."><plain>Blood counts of patients with <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with mutations in telomerase genes can improve with <z:chebi fb="3" ids="50113">androgen</z:chebi> therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Here we observed that exposure in vitro of <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood lymphocytes and human bone marrow-derived CD34(+) cells to <z:chebi fb="5" ids="50113">androgens</z:chebi> increased telomerase activity, coincident with higher TERT <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels </plain></SENT>
<SENT sid="3" pm="."><plain>Cells from patients who were heterozygous for telomerase mutations had low baseline telomerase activity, which was restored to <z:mpath ids='MPATH_458'>normal</z:mpath> levels by exposure to <z:chebi fb="5" ids="50113">androgens</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="1" ids="23965">Estradiol</z:chebi> had an effect similar to <z:chebi fb="5" ids="50113">androgens</z:chebi> on TERT gene expression and telomerase enzymatic activity </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="3" ids="41774">Tamoxifen</z:chebi> abolished the effects of both <z:chebi fb="1" ids="23965">estradiol</z:chebi> and <z:chebi fb="5" ids="50113">androgens</z:chebi> on telomerase function, and <z:chebi fb="0" ids="6413">letrozole</z:chebi>, an <z:chebi fb="0" ids="50790">aromatase inhibitor</z:chebi>, blocked <z:chebi fb="3" ids="50113">androgen</z:chebi> effects on telomerase activity </plain></SENT>
<SENT sid="6" pm="."><plain>Conversely, <z:chebi fb="0" ids="5132">flutamide</z:chebi>, an <z:chebi fb="3" ids="50113">androgen</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, did not affect <z:chebi fb="3" ids="50113">androgen</z:chebi> stimulation of telomerase </plain></SENT>
<SENT sid="7" pm="."><plain>Down-regulation by siRNA of <z:chebi fb="0" ids="50114">estrogen</z:chebi> receptor-alpha (ER alpha), but not ER beta, inhibited <z:chebi fb="0" ids="50114">estrogen</z:chebi>-stimulated telomerase function </plain></SENT>
<SENT sid="8" pm="."><plain>Our results provide a mechanism for <z:chebi fb="3" ids="50113">androgen</z:chebi> therapy in <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo>: <z:chebi fb="5" ids="50113">androgens</z:chebi> appear to regulate telomerase expression and activity mainly by aromatization and through ER alpha </plain></SENT>
<SENT sid="9" pm="."><plain>These findings have potential implications for the choice of current androgenic compounds and the development of future agents for clinical use </plain></SENT>
</text></document>